- Home
- / Exscientia
Exscientia
Revenue
£20.1 M
FY, 2023
Exscientia Summary
Company Summary
- Overview
- Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. It offers the Patient-First AI oncology platform and focuses on target identification, custom-designed solutions, data collection, and precision medicine.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2012
- HQ
- Oxford, GB | view all locations
- Website
- https://www.exscientia.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Garry Pairaudeau, Chief Technology Officer
Ben Taylor, CFO, Chief Strategy Officer & Executive Director
Richard Bickerton, Chief Data Officer & Chief Systems Scientist
LocationsView all
5 locations detected
Oxford, England HQ
United Kingdom
The Schrödinger Building , Oxford Science Park
Miami, FL
United States
2125 Biscayne Blvd #400e
Wien, Wien
Austria
Campus-Vienna-Biocenter 5
Osaka, Osaka
Japan
2-chōme-2-2-19F Umeda, Kita Ward
Dundee, Scotland
United Kingdom
Dundee One, RiverCourt, 5 West Victoria Dock Road
Exscientia Financials
Summary Financials
- Revenue (Q2, 2024)
- £4.4M
- Gross profit (Q2, 2024)
- £5.0M
- Net income (Q2, 2024)
- (£36.2M)
- Cash (Q2, 2024)
- £139.3M
- EBIT (Q2, 2024)
- (£39.7M)